Principal Financial Group’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $276K | Buy |
+5,667
| New | +$276K | ﹤0.01% | 2089 |
|
|
2024
Q3 | – | Sell |
-7,052
| Closed | -$381K | – | 2268 |
|
|
2024
Q2 | $381K | Sell |
7,052
-33,418
| -83% | -$1.8M | ﹤0.01% | 2016 |
|
|
2024
Q1 | $2.76M | Buy |
+40,470
| New | +$2.76M | ﹤0.01% | 1729 |
|
|
2022
Q4 | – | Sell |
-9,059
| Closed | -$592K | – | 2462 |
|
|
2022
Q3 | $592K | Buy |
9,059
+265
| +3% | +$17.3K | ﹤0.01% | 1927 |
|
|
2022
Q2 | $534K | Sell |
8,794
-21
| -0.2% | -$1.28K | ﹤0.01% | 2044 |
|
|
2022
Q1 | $553K | Sell |
8,815
-344
| -4% | -$21.6K | ﹤0.01% | 2093 |
|
|
2021
Q4 | $694K | Sell |
9,159
-6,043
| -40% | -$458K | ﹤0.01% | 2051 |
|
|
2021
Q3 | $1.7M | Sell |
15,202
-2,427
| -14% | -$272K | ﹤0.01% | 1899 |
|
|
2021
Q2 | $2.85M | Buy |
17,629
+1,875
| +12% | +$304K | ﹤0.01% | 1836 |
|
|
2021
Q1 | $1.92M | Buy |
+15,754
| New | +$1.92M | ﹤0.01% | 1862 |
|